Richard G. Vincent

Richard G. Vincent joined Genoa in June 2011 and serves as our Chief Financial Officer. Mr. Vincent previously held senior management positions at Meritage Pharma, Sorrento Therapeutics, Elevation Pharmaceuticals, Verus Pharmaceuticals, Women First HealthCare, Elan Pharmaceuticals, Phase Metrics, and Deloitte &a; Touche LLP, where he specialized in emerging growth and publicly-reporting companies. Over the past 20+ years, Mr. Vincent's experience includes raising over $500 million through venture capital, major commercial banks and institutions, and public offering proceeds for high growth pharmaceutical and technology-based companies, and participating in a number of acquisitions and divestitures valued at over $900 million. Mr. Vincent became a Certified Public Accountant in California and holds a B.S. degree in business from San Diego State University.